[AO-01] Oral Presentation Award Nominee Session (Basic Research)

[AO-01-3] A centrally acting connexin hemichannel blocker attenuates multiple system atrophy-cerebellar type

Masaya Harada^1,2, Katsuhisa Masaki¹, Dai Matsuse¹, Hiroo Yamaguchi^1,3, Yuji Nishimura¹, Ezgi Ozdemir¹, Eizo Tanaka¹, Tatsunori Tanaka⁴, Ryo Yamasaki¹, Hideyuki Takeuchi⁵, Takayuki Taniwaki², Noriko Isobe¹, Jun-ichi Kira^1,6,7 (1.Department of Neurology, Neurological Institute, Graduate School of Medical Sciences, Kyushu University, Japan, 2.Division of Respirology, Neurology and Rheumatology, Department of Medicine, Kurume University School of Medicine, Japan, 3.School of Physical Therapy, Faculty of Rehabilitation, Reiwa Health Science University, Fukuoka, Japan, 4.Sumitomo Pharma Co., Ltd., Osaka, Japan, 5.School of Medicine Medical Course, Neurology and Stroke Medicine Graduate School of Medicine Degree Program, Yokohama City University, Japan, 6.Translational Neuroscience Center, Graduate School of Medicine, and School of Pharmacy at Fukuoka, International University of Health and Welfare, Japan, 7.Department of Neurology, Brain and Nerve Center, Fukuoka Central Hospital, Japan)